Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Gilead reports positive results in HDV patients previously unresponsive to therapy
Motley Fool
Sun, 06/25/23 - 09:35 pm
Tags:
Gilead Sciences
,
MYR301
,
Hepcludex
,
hepatitis B
,
clinical trials
Kite's Yescarta CAR T-cell Therapy Shows Extended Survival in Relapsed/Refractory Large B-cell Lymphoma
Businesswire
Tue, 06/6/23 - 10:11 am
Tags:
ASCO 2023
,
Gilead Sciences
,
Kite Pharma
,
Yescarta
,
relapsed or refractory large B-cell lymphoma
ASCO: Gilead and Arcus's Cancer Immunotherapy Combo Faces Scrutiny Over Lower Survival Rates
BioSpace
Sun, 06/4/23 - 04:27 pm
Tags:
ASCO 2023
,
Gilead Sciences
,
Arcus Biosciences
,
anti-TIGIT
,
non-small cell lung cancer
,
domvanalimab
US appeal in high-stakes Gilead patent case garners support from patient advocates
Fierce Pharma
Thu, 06/1/23 - 11:27 am
Tags:
Gilead Sciences
,
HIV
,
patents
,
legal
,
DOJ
,
Truvada
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Fierce Pharma
Mon, 05/29/23 - 12:26 pm
Tags:
Gilead Sciences
,
Teva Pharmaceutical
,
HIV
,
legal
,
antitrust
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Thu, 05/25/23 - 01:10 pm
Tags:
Gilead Sciences
,
Teva Pharmaceutical
,
legal
,
HIV
,
antitrust
Gilead picks former Roche executive to run cell therapy unit Kite
BioPharma Dive
Wed, 05/17/23 - 11:14 am
Tags:
Gilead Sciences
,
Roche
,
Kite Pharma
,
cell therapy
,
Cindy Perettie
,
women executives
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Tags:
Gilead Sciences
,
GSK
,
momelotinib
,
Roche
,
Eli Lilly
,
lebrikizumab
,
Merck
,
Zejula
,
Amgen
,
Galenica
,
Veltassa
,
Cubicin
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
Gilead notches trial win in high-stakes HIV patent case against US government
Fierce Pharma
Tue, 05/9/23 - 11:32 pm
Tags:
Gilead Sciences
,
Truvada
,
HIV
,
Descovy
,
legal
,
patents
After FDA rejection, Gilead nears full EU nod for hep D drug
Pharmaphorum
Fri, 05/5/23 - 11:15 am
Tags:
Gilead Sciences
,
hepatitis D
,
FDA
,
Europe
,
Hepcludex
,
buleviritide
Gilead Sciences Stock Has Only Done This in 1 of the Past 7 Years
Motley Fool
Fri, 05/5/23 - 10:16 am
Tags:
Gilead Sciences
Gilead, US government set for courtroom showdown over PrEP drug patents
Fierce Pharma
Tue, 05/2/23 - 11:45 am
Tags:
Gilead Sciences
,
legal
,
patents
,
Truvada
,
Descovey
,
PrEP
Q1 revenues slide for Amgen, Gilead
Medical Marketing and Media
Thu, 04/27/23 - 10:54 pm
Tags:
Amgen
,
Gilead Sciences
,
earnings
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D
,
Amgen
,
Bayer
,
Biogen
,
Gilead Sciences
,
Merck KGaA
,
Moderna Therapeutics
,
Novo Nordisk
,
Regeneron Pharmaceuticals
,
UCB
,
Vertex Pharmaceuticals
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
Tags:
biotech
,
clinical trials
,
Alnylam Pharmaceuticals
,
Arcus Biosciences
,
Argenx
,
Arrowhead Pharmaceuticals
,
Axsome Therapeutics
,
Bavarian Nordic
,
FibroGen
,
Gilead Sciences
,
Incyte
,
Morphic Therapeutic
,
PTC Therapeutics
,
Syndax Pharmaceuticals
,
Travere Therapeutics
,
Vaxcyte
Gilead’s Yescarta extends survival in lymphoma study
BioPharma Dive
Tue, 03/21/23 - 09:53 pm
Tags:
Gilead Sciences
,
Yescarta
,
CAR-T
,
lymphoma
,
large B-cell lymphoma
Gilead gets big $175m judgment in HIV fraud case
Pharmaphorum
Fri, 03/10/23 - 09:55 am
Tags:
Gilead Sciences
,
HIV
,
fraud
,
legal
,
reimbursement
Gilead plans to invest $47M+ to boost its capacity in southern Ireland
Endpoints
Tue, 03/7/23 - 10:19 pm
Tags:
Gilead Sciences
,
Ireland
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.